Lanxin Liu

573 total citations
12 papers, 412 citations indexed

About

Lanxin Liu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Lanxin Liu has authored 12 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Lanxin Liu's work include Epigenetics and DNA Methylation (7 papers), Genomics and Chromatin Dynamics (5 papers) and Cancer-related gene regulation (4 papers). Lanxin Liu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Genomics and Chromatin Dynamics (5 papers) and Cancer-related gene regulation (4 papers). Lanxin Liu collaborates with scholars based in United States and China. Lanxin Liu's co-authors include Yuanyuan Jiang, Zeng-Quan Yang, Hui Liu, Andreana Holowatyj, Zeng-Quan Yang, Wenqi Shan, Xuhui Guo, Huimei Yu, Qianhui Huang and Qing‐Sheng Mi and has published in prestigious journals such as Scientific Reports, Oncotarget and Advances in experimental medicine and biology.

In The Last Decade

Lanxin Liu

11 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lanxin Liu United States	10	362	103	56	29	19	12	412
Merve Çakır United States	7	244 0.7×	66 0.6×	81 1.4×	32 1.1×	31 1.6×	9	340
Wen Guan China	11	183 0.5×	81 0.8×	47 0.8×	27 0.9×	25 1.3×	20	273
Sen-Hao Xiao China	12	234 0.6×	65 0.6×	35 0.6×	17 0.6×	20 1.1×	14	298
Xiuyi Yu China	12	236 0.7×	99 1.0×	82 1.5×	62 2.1×	26 1.4×	24	371
Geetika Sethi United States	8	313 0.9×	145 1.4×	55 1.0×	49 1.7×	44 2.3×	8	421
Hanwen Xu United States	10	193 0.5×	75 0.7×	70 1.3×	25 0.9×	29 1.5×	18	292
Kyla Geary United States	8	222 0.6×	59 0.6×	98 1.8×	65 2.2×	19 1.0×	13	327
Almut Brand Germany	3	182 0.5×	131 1.3×	39 0.7×	14 0.5×	27 1.4×	4	243
Christina D. Drenberg United States	9	205 0.6×	39 0.4×	84 1.5×	27 0.9×	25 1.3×	11	302
Rong-quan Xiao China	11	470 1.3×	58 0.6×	31 0.6×	21 0.7×	32 1.7×	12	511

Countries citing papers authored by Lanxin Liu

Since Specialization

Citations

This map shows the geographic impact of Lanxin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxin Liu more than expected).

Fields of papers citing papers by Lanxin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxin Liu. The network helps show where Lanxin Liu may publish in the future.

Co-authorship network of co-authors of Lanxin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxin Liu. A scholar is included among the top collaborators of Lanxin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxin Liu. Lanxin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zhang, Yan, Yan Wang, Xiangyu Wang, et al.. (2025). Neuroprotective Effects, Mechanisms of Action and Therapeutic Potential of the Kv7/KCNQ Channel Opener QO-83 in Ischemic Stroke. Translational Stroke Research. 16(5). 1577–1593.

Jiang, Yuanyuan, Lanxin Liu, & Zeng-Quan Yang. (2023). KDM4 Demethylases: Structure, Function, and Inhibitors. Advances in experimental medicine and biology. 1433. 87–111. 3 indexed citations

Jiang, Yuanyuan, et al.. (2021). Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer. Scientific Reports. 11(1). 14784–14784. 41 indexed citations

Jiang, Yuanyuan, et al.. (2020). Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus. Journal of Biomolecular Structure and Dynamics. 40(3). 1331–1346. 29 indexed citations

Jiang, Yuanyuan, et al.. (2020). Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression. RNA Biology. 17(4). 474–486. 32 indexed citations

Jiang, Yuanyuan, et al.. (2020). Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features. Cancer Science. 111(5). 1829–1839. 19 indexed citations

Guo, Xuhui, et al.. (2017). Genotranscriptomic meta‐analysis of the CHD family chromatin remodelers in human cancers – initial evidence of an oncogenic role for CHD7. Molecular Oncology. 11(10). 1348–1360. 26 indexed citations

Shan, Wenqi, Yuanyuan Jiang, Huimei Yu, et al.. (2017). HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.. PubMed. 7(5). 1213–1226. 62 indexed citations

Yu, Huimei, Yuanyuan Jiang, Lanxin Liu, et al.. (2016). Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer. Oncotarget. 8(8). 13099–13115. 17 indexed citations

10.

Jiang, Yuanyuan, Lanxin Liu, Wenqi Shan, & Zeng-Quan Yang. (2015). An integrated genomic analysis of Tudor domain–containing proteins identifies PHD finger protein 20‐like 1 (PHF20L1) as a candidate oncogene in breast cancer. Molecular Oncology. 10(2). 292–302. 24 indexed citations

11.

Liu, Hui, Lanxin Liu, Andreana Holowatyj, Yuanyuan Jiang, & Zeng-Quan Yang. (2015). Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Molecular Carcinogenesis. 55(5). 977–990. 36 indexed citations

12.

Liu, Lanxin, et al.. (2014). Genetic alterations of histone lysine methyltransferases and their significance in breast cancer. Oncotarget. 6(4). 2466–2482. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact